Elite in Optic Nerve Atrophy

Dr. Nancy J. Newman

Ophthalmology | Neurology
Emory Medical Care Foundation Inc
80 Jesse Hill Jr Dr Se, 
Atlanta, GA 
Accepting New Patients
Offers Telehealth
Elite in Optic Nerve Atrophy
Emory Medical Care Foundation Inc
80 Jesse Hill Jr Dr Se, 
Atlanta, GA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Nancy Newman is an Ophthalmologist and a Neurologist in Atlanta, Georgia. Dr. Newman is rated as an Elite provider by MediFind in the treatment of Optic Nerve Atrophy. Her top areas of expertise are Leber Hereditary Optic Neuropathy (LHON), Optic Nerve Atrophy, Increased Intracranial Pressure, Pseudotumor Cerebri Syndrome, and Embolectomy. Dr. Newman is currently accepting new patients.

Her clinical research consists of co-authoring 240 peer reviewed articles and participating in 7 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 33 articles and participated in 6 clinical trials in the study of Optic Nerve Atrophy.

Specialties
Ophthalmology
Neurology
Licenses
Ophthalmology in GA
Hospital Affiliations
Grady Memorial Hospital
Emory University Hospital
Languages Spoken
English
Spanish
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Oscar
  • EPO
  • HMO
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 5 Less Insurance Carriers -

Locations

EMORY MEDICAL CARE FOUNDATION INC
80 Jesse Hill Jr Dr Se, Atlanta, GA 30303
Other Locations
THE EMORY CLINIC INC
1365 Clifton Rd Ne, Atlanta, GA 30322

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

Long-term Follow-up of ND4 LHON Subjects Treated With GS010 Ocular Gene Therapy in the RESCUE or REVERSE Phase III Clinical Trials (RESTORE)
Long-term Follow-up of ND4 LHON Subjects Treated With GS010 Ocular Gene Therapy in the RESCUE or REVERSE Phase III Clinical Trials (RESTORE)
Enrollment Status: Completed
Publish Date: September 09, 2025
Intervention Type: Genetic, Other
Study Phase: Phase 3
Efficacy and Safety of Bilateral Intravitreal Injection of GS010: A Randomized, Double-Masked, Placebo-Controlled Trial in Subjects Affected With G11778A ND4 Leber Hereditary Optic Neuropathy for Up to One Year
Efficacy and Safety of Bilateral Intravitreal Injection of GS010: A Randomized, Double-Masked, Placebo-Controlled Trial in Subjects Affected With G11778A ND4 Leber Hereditary Optic Neuropathy for Up to One Year
Enrollment Status: Completed
Publish Date: August 26, 2025
Intervention Type: Drug, Genetic
Study Phase: Phase 3
External Natural History Controlled, Open-Label Intervention Study to Assess the Efficacy and Safety of Long-Term Treatment With Raxone® in Leber's Hereditary Optic Neuropathy (LHON)
External Natural History Controlled, Open-Label Intervention Study to Assess the Efficacy and Safety of Long-Term Treatment With Raxone® in Leber's Hereditary Optic Neuropathy (LHON)
Enrollment Status: Completed
Publish Date: April 21, 2023
Intervention Type: Drug
Study Phase: Phase 4
A Randomized, Double-Masked, Sham-Controlled Clinical Trial to Evaluate the Efficacy of a Single Intravitreal Injection of GS010 in Subjects Affected for 6 Months or Less by LHON Due to the G11778A Mutation in the Mitochondrial ND4 Gene
A Randomized, Double-Masked, Sham-Controlled Clinical Trial to Evaluate the Efficacy of a Single Intravitreal Injection of GS010 in Subjects Affected for 6 Months or Less by LHON Due to the G11778A Mutation in the Mitochondrial ND4 Gene
Enrollment Status: Completed
Publish Date: July 29, 2022
Intervention Type: Biological, Device
Study Phase: Phase 3
Observational Registry Study of Leber Hereditary Optic Neuropathy (LHON) Affected Patients
Observational Registry Study of Leber Hereditary Optic Neuropathy (LHON) Affected Patients
Enrollment Status: Completed
Publish Date: February 08, 2021
Intervention Type: Other
A Double-Masked Clinical Study Evaluating the Efficacy and Safety of RPh201 Treatment in Participants With Previous NAION
A Double-Masked Clinical Study Evaluating the Efficacy and Safety of RPh201 Treatment in Participants With Previous NAION
Enrollment Status: Terminated
Publish Date: October 12, 2020
Intervention Type: Other, Drug
Study Phase: Phase 2
Randomized, Double-Masked, Sham-Controlled Clinical Trial to Evaluate the Efficacy of a Single Intravitreal Injection of GS010 in Subjects Affected for More Than 6 Months and To 12 Months by LHON Due to the G11778A Mutation in the ND4 Gene
Randomized, Double-Masked, Sham-Controlled Clinical Trial to Evaluate the Efficacy of a Single Intravitreal Injection of GS010 in Subjects Affected for More Than 6 Months and To 12 Months by LHON Due to the G11778A Mutation in the ND4 Gene
Enrollment Status: Completed
Publish Date: January 23, 2020
Intervention Type: Biological, Device
Study Phase: Phase 3
View 6 Less Clinical Trials

234 Total Publications

Predictors of Final Visual Outcome in Patients With Leber Hereditary Optic Neuropathy Treated With Lenadogene Nolparvovec Gene Therapy.
Predictors of Final Visual Outcome in Patients With Leber Hereditary Optic Neuropathy Treated With Lenadogene Nolparvovec Gene Therapy.
Journal: Investigative ophthalmology & visual science
Published: July 15, 2025
Similar Doctors
Valerie Biousse
Elite in Optic Nerve Atrophy
Dr. Valerie Biousse
Ophthalmology | Neurology
Elite in Optic Nerve Atrophy
Dr. Valerie Biousse
Ophthalmology | Neurology

Emory Eye Center

1365 Clifton Road Northeast, BldgB, 
Atlanta, GA 
 (4.3 miles away)
404-778-2020
Experience:
37+ years
Languages Spoken:
English, French
See accepted insurances

Valerie Biousse is an Ophthalmologist and a Neurologist in Atlanta, Georgia. Dr. Biousse has been practicing medicine for over 37 years and is rated as an Elite provider by MediFind in the treatment of Optic Nerve Atrophy. Her top areas of expertise are Increased Intracranial Pressure, Pseudotumor Cerebri Syndrome, Papilledema, Optic Nerve Atrophy, and Embolectomy.

Distinguished in Optic Nerve Atrophy
Dr. Gayle L. Leff-Goldstein
Ophthalmology
Distinguished in Optic Nerve Atrophy
Dr. Gayle L. Leff-Goldstein
Ophthalmology

Eugene B Gabianelli MD And Assoc LLC

550 Peachtree St Ne, Suite 1500, 
Atlanta, GA 
 (1.1 miles away)
404-897-6810
Languages Spoken:
English, Italian, Spanish
See accepted insurances
Accepting New Patients

Gayle Leff-Goldstein is an Ophthalmologist in Atlanta, Georgia. Dr. Leff-Goldstein is rated as a Distinguished provider by MediFind in the treatment of Optic Nerve Atrophy. Her top areas of expertise are Blepharitis, Cataract, Glaucoma, and Optic Nerve Atrophy. Dr. Leff-Goldstein is currently accepting new patients.

Advanced in Optic Nerve Atrophy
Dr. Michael Dattilo
Ophthalmology
Advanced in Optic Nerve Atrophy
Dr. Michael Dattilo
Ophthalmology

Emory Eye Center

1365 Clifton Road Northeast, BldgB, 
Atlanta, GA 
 (4.3 miles away)
404-778-2020
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Michael Dattilo is an Ophthalmologist in Atlanta, Georgia. Dr. Dattilo is rated as a Distinguished provider by MediFind in the treatment of Optic Nerve Atrophy. His top areas of expertise are Papilledema, Increased Intracranial Pressure, Optic Neuritis, and Optic Nerve Atrophy.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Newman's expertise for a condition
ConditionClose
View All 11 Advanced Conditions
View All 31 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile